{"id":47288,"date":"2022-08-15T16:02:25","date_gmt":"2022-08-15T14:02:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\/"},"modified":"2022-08-15T16:02:25","modified_gmt":"2022-08-15T14:02:25","slug":"heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\/","title":{"rendered":"Heart Health Innovator Cleerly Appoints Joseph Jasser, MD, as Chief of Value Based Care"},"content":{"rendered":"
\n

\nHire follows Cleerly\u2019s $223 million Series C and furthers value-based care business strategy<\/i>\n<\/p>\n

NEW YORK–(BUSINESS WIRE)–Cleerly<\/a>, the company creating a new standard of care for heart disease, announced it has appointed Joseph \u201cJoe\u201d Jasser, MD, as chief of value based care. In this role, Dr. Jasser will be responsible for developing and executing the initial business plan and go-to-market strategy for the value-based care client segment. He will also lead the commercial and client services teams for Cleerly’s Value Based Care vertical, and will report to Jim Hartman, chief revenue officer of Cleerly.\n<\/p>\n

<\/a><\/p>\n

\n\u201cI’m very excited to have Joe join us on our mission to create a world without heart attacks,\u201d Hartman said. \u201cHis knowledge of and passion for designing tailored solutions to provide an excellent patient experience, while also optimizing the clinical and financial outcomes of a value-based care model for clients, makes him a natural fit for the Cleerly team. Joe has impressive experience as a builder of highly successful value-based care models \u2013 whether he’s working in a health system, health plan or business-to-business organization within the healthcare industry.\u201d\n<\/p>\n

\nPrior to joining Cleerly, Dr. Jasser was chief medical officer of Vesta Healthcare and previously, he was the chief medical officer of bclinical, PLLC where he provided clinical consultative services for clinical delivery organizations and medical groups. He has also served as the chief medical officer and executive vice president of complex care management at Signify Health and was the president of care delivery for Humana, Inc. Additionally, Dr. Jasser served as the president and CEO of Dignity Health Medical Foundation and held roles at Cigna-HealthSpring, CIGNA and Concentra.\n<\/p>\n

\nDr. Jasser earned his Bachelor of Science degree from The Ohio State University, his medical degree from The Ohio State University College of Medicine and an Executive Master of Business Administration from Washington State University. He completed his residency at Summa Health System and is board certified in internal medicine.\n<\/p>\n

\n\u201cI\u2019m excited about what Cleerly can and will do for cardiovascular disease; it\u2019s disruptive and revolutionary,\u201d Dr. Jasser said. \u201cI look forward to building Cleerly\u2019s value-based care client segment with a variety of solutions for health plans and providers that offer a new, improved standard of cardiovascular care to patients.\u201d\n<\/p>\n

\nThis appointment comes after Cleerly\u2019s recently announced<\/a> Series C funding round of $223 million led by T. Rowe Price and Fidelity.\n<\/p>\n

\nAbout Cleerly
\n
<\/b>Cleerly is the company creating a new standard of care for heart disease. Through value-based precision diagnostic solutions driven by machine intelligence, Cleerly enables comprehensive phenotyping of coronary artery disease, as determined from advanced non-invasive CT imaging. Led by a world-class clinical and technical team, Cleerly enhances health literacy for each and every stakeholder in the coronary care pathway. For more information, please visit: https:\/\/www.cleerlyhealth.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nKristin Binns
<\/b>press@cleerlyhealth.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Hire follows Cleerly\u2019s $223 million Series C and furthers value-based care business strategy NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced it has appointed Joseph \u201cJoe\u201d Jasser, MD, as chief of value based care. In this role, Dr. Jasser will be responsible for developing and executing the initial … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47288","6":"format-standard","7":"category-industry"},"yoast_head":"\nHeart Health Innovator Cleerly Appoints Joseph Jasser, MD, as Chief of Value Based Care - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Heart Health Innovator Cleerly Appoints Joseph Jasser, MD, as Chief of Value Based Care - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Hire follows Cleerly\u2019s $223 million Series C and furthers value-based care business strategy NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced it has appointed Joseph \u201cJoe\u201d Jasser, MD, as chief of value based care. In this role, Dr. Jasser will be responsible for developing and executing the initial ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-15T14:02:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220815005101\/en\/1543354\/21\/cleerly-wordmark-full-color_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Heart Health Innovator Cleerly Appoints Joseph Jasser, MD, as Chief of Value Based Care\",\"datePublished\":\"2022-08-15T14:02:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\\\/\"},\"wordCount\":489,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220815005101\\\/en\\\/1543354\\\/21\\\/cleerly-wordmark-full-color_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\\\/\",\"name\":\"Heart Health Innovator Cleerly Appoints Joseph Jasser, MD, as Chief of Value Based Care - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220815005101\\\/en\\\/1543354\\\/21\\\/cleerly-wordmark-full-color_%281%29.jpg\",\"datePublished\":\"2022-08-15T14:02:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220815005101\\\/en\\\/1543354\\\/21\\\/cleerly-wordmark-full-color_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220815005101\\\/en\\\/1543354\\\/21\\\/cleerly-wordmark-full-color_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Heart Health Innovator Cleerly Appoints Joseph Jasser, MD, as Chief of Value Based Care\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Heart Health Innovator Cleerly Appoints Joseph Jasser, MD, as Chief of Value Based Care - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\/","og_locale":"en_US","og_type":"article","og_title":"Heart Health Innovator Cleerly Appoints Joseph Jasser, MD, as Chief of Value Based Care - Pharma Trend","og_description":"Hire follows Cleerly\u2019s $223 million Series C and furthers value-based care business strategy NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced it has appointed Joseph \u201cJoe\u201d Jasser, MD, as chief of value based care. In this role, Dr. Jasser will be responsible for developing and executing the initial ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-15T14:02:25+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220815005101\/en\/1543354\/21\/cleerly-wordmark-full-color_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Heart Health Innovator Cleerly Appoints Joseph Jasser, MD, as Chief of Value Based Care","datePublished":"2022-08-15T14:02:25+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\/"},"wordCount":489,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220815005101\/en\/1543354\/21\/cleerly-wordmark-full-color_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\/","url":"https:\/\/pharma-trend.com\/en\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\/","name":"Heart Health Innovator Cleerly Appoints Joseph Jasser, MD, as Chief of Value Based Care - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220815005101\/en\/1543354\/21\/cleerly-wordmark-full-color_%281%29.jpg","datePublished":"2022-08-15T14:02:25+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220815005101\/en\/1543354\/21\/cleerly-wordmark-full-color_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220815005101\/en\/1543354\/21\/cleerly-wordmark-full-color_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Heart Health Innovator Cleerly Appoints Joseph Jasser, MD, as Chief of Value Based Care"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47288","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47288"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47288\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47288"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47288"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47288"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}